Curcumin regulated shift from Th1 to Th2 in trinitrobenzene sulphonic acid-induced chronic colitis

Acta Pharmacologica Sinica

Volumn 27, Issue 8, 2006, Pages 1071-1077

  Zhang, Ming ^c   Deng, Chang Sheng ^a   Zheng, Jia Ju ^b   Xia, Jian ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Third People's Hospital of Suzhou   (China)

^c THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

Colitis; Curcumin; IL 12; IL 4; Th1; Th2

Indexed keywords

CURCUMIN; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MESSENGER RNA; MYELOPEROXIDASE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLITIS; COLON MUCOSA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOLOGY; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; SPLEEN CELL; TH1 CELL; TH2 CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS; COLON; CURCUMIN; CYTOKINES; DEXAMETHASONE; INTERFERON TYPE II; INTERLEUKIN-12; INTESTINAL MUCOSA; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746399418     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2006.00322.x     Document Type: Article

References (24)

1. Ammon HPT, Wahl MA. Pharmacology of curcuma longa. Planta Med 1991; 57: 1-7.
2. + T cells by suppressing interleukin-12 production in macrophages. Br J Pharmacol 1999; 128: 380-4.
3. Kang BY, Chung SW, Chung W, Im S, Hwang SY, Kim TS. Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. Eur J Pharmacol 1999; 19: 191-5.
4. Kobayashi T, Hashimoto S, Horie T. Curcumin inhibition of dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. Biochem Pharmacol 1997; 54: 819-24.
5. Schmidt C, Stallmach A. Etiology and pathogenesis of inflammatory bowel disease. Minerva Gastroenterol Dietol 2005; 51: 127-45.
6. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995; 109: 1344-67.
7. Elson CO, Beagley KW, Sharmanov AT, Fujihashi K, Kiyono H, Tennyson GS, et al. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. J Immunol 1996; 157: 2174-85.
8. Tozawa K, Hanai H, Sugimoto K, Baba S, Sugimura H, Aoshi T, et al. Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice. J Gastroenterol Hepatol 2003; 18: 578-87.
9. Salh B, Assi K, Templeman V, Parhar K, Owen D, Gomez-Munoz A, et al. Curcumin attenuates DNB-induced murine colitis. Am J Physiol Gastrointest Liver Physiol 2003; 285: G235-43.
10. Sugimoto K, Hanai H, Tozawa K, Aoshi T, Uchijima M, Nagata T, et al. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 2002; 123: 1912-22.
11. Ukil A, Maity S, Karmakar S, Datta N, Vedasiromoni JR, Das PK. Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis. Br J Pharmacol 2003; 139: 209-18.
12. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace IL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803.
13. Maisel A, Cesario D, Baird S, Rehman J, Haghighi P, Carter S. Experimental autoimmune myocarditis produced by adoptive transfer of splenocytes after myocardial infarction. Circ Res 1998; 82: 458-63.
14. Egi H, Hayamizu K, Yoshimitsu M, Shimamoto F, Oishi K, Ohmori I, et al. Regulation of T helper type-1 immunity in hapten-induced colitis by host pretreatment with granulocyte colony-stimulating factor. Cytokine 2003; 23: 23-30.
15. Colon AL, Menchen LA, Hurtado O, De Cristobal J, Lizasoain I, Leza JC, et al. Implication of TNF-alpha convertase (TACE/ ADAM17) in inducible nitric oxide synthase expression and inflammation in an experimental model of colitis. Cytokine 2001; 16: 220-6.
16. Caspi RR. IL-12 in autoimmunity. Clin Immunol Immunopathol 1998; 88: 4-13.
17. Chandramohan N, John JB. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through janus kinase-STAT pathway in T lymphocytes. J Immunol 2002; 169: 6506-13.
18. + lymphocytes by inhibiting IL-12 production. J Immunol 1998; 160: 2231-7.
19. Cao W, Chen Y, Alkan S, Subramaniam A, Long F, Liu H, et al. Human T helper (Th) cell lineage commitment is not directly linked to the secretion of IFN-gamma or IL-4: characterization of Th cells isolated by FACS based on IFN-gamma and IL-4 secretion. Eur J Immunol 2005; 35: 2709-17.
20. Xie QM, Chen JQ, Shen WH, Bian RL. Correlative changes of interferon-gamma and interleukin-4 between cortical layer and pulmonary airway of sensitized rats. Acta Pharmacol Sin 2002; 23: 248-52.
21. Sarah GH, Josue P, Laura K, Denise R, Richard PP. Prostaglandins as modulators of immunity. Trends Immunol 2002; 23: 144-50.
22. Pereira MA, Grubbs CJ, Barnes LH, Li H, Olson GR, Eto I, et al. Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a] anthracene-induced mammary cancer in rats. Carcinogenesis 1996; 17: 1305-11.
23. Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S, et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 1999; 18: 6013-20.
24. Elenkov IJ. Glucocorticoids and the Th1/Th2 balance. Ann N Y Acad Sci 2004; 1024: 138-46.